The FDA on Thursday approved a new class of pain medication that provides an alternative to opioids. It will be sold under ...

The FDA has approved Journavx, an oral medication for treating pain that doesn't target the brain like addictive opioids.

More New Yorkers received scripts for buprenorphine, a med used to treat opioid addiction, amid fight against record-high ...

A new opioid-free pain medication was approved by the U.S. Food and Drug Administration (FDA) on Thursday, marking a non-addictive alternative for patients. Journavx (suzetrigine), made by Vertex ...

Vertex Pharmaceuticals (VRTX) stock rose on Friday after the Food and Drug Administration (FDA) approved its new painkiller, the first of its kind approved by regulators. Journavx, or suzetrigine ...

Journavx (suzetrigine), a non-opioid pill for moderate-to-severe acute pain, has just received FDA approval. It’s the first drug in a new family of medicines that block pain signals before they ...